Introduction
============

Epidural and combined spinal--epidural (CSE) techniques are widely considered as the most effective means of providing labor analgesia[@b1-jpr-10-2789],[@b2-jpr-10-2789] and have been found to increase patient satisfaction compared to other modalities.[@b2-jpr-10-2789] Traditionally, the epidural catheter is placed, aspirated, and a test dose of medication is given to detect the possibility of an intravascular (IV) or intrathecal (IT) catheter prior to administering additional doses of local anesthetic and opioids. There have been very few studies in which anesthesia providers have initiated labor analgesia by injecting medications through the epidural needle immediately after loss of resistance in order to achieve faster onset of pain relief.[@b3-jpr-10-2789] Provision of neuraxial labor analgesia in a timely manner has been shown to be important to many parturients on open-ended patient surveys.[@b4-jpr-10-2789] Thus, it is important to examine the efficacy and safety of epidural dosing techniques that may shorten analgesic onset. Dosing prior to placement of the catheter, such as with a CSE or through the epidural needle, may have the additional benefit of allowing labor analgesia to commence in instances which catheter placement is in an epidural vein and additional procedure time is necessary.

In addition to faster onset of analgesia, it has been reported that dosing through the epidural needle may result in improved quality of epidural anesthesia compared to dosing through the catheter.[@b5-jpr-10-2789] However, other investigations in obstetric[@b6-jpr-10-2789] and non-obstetric[@b7-jpr-10-2789] patients receiving epidural anesthesia have observed similar onset and quality of surgical anesthesia as well as similar level of sensory blockade when dosing through the needle versus the catheter. To our knowledge, there have been no direct comparisons of needle and catheter injection of epidural medications for the initiation of labor analgesia.

The rationale for potentially improved analgesia onset with epidural needle injection is uncertain. More rapid injection is often possible through the epidural needle given the relatively larger gauge and shorter length compared to a catheter,[@b8-jpr-10-2789] which could potentially enhance the spread of medication within the epidural space. Suboptimal epidural catheter position has been suggested to play a role in limiting spread of injected medication and quality of analgesia,[@b5-jpr-10-2789] and radiological studies have demonstrated that catheter position in the anterior or lateral epidural space may lead to one-sided or asymmetric blockade.[@b9-jpr-10-2789],[@b10-jpr-10-2789] Injection from an epidural needle tip that lies in a more posterior location within the epidural space may be more likely to result in bilateral spread compared to injection through an epidural catheter, which may more likely lie in the lateral or anterior epidural space. Finally, the injection of epidural saline after loss of resistance is commonly done to reduce the incidence of an IV catheter placement,[@b11-jpr-10-2789] but this may dilute subsequent local anesthetic administered.[@b12-jpr-10-2789] Predistension of the epidural space with local anesthetic solution could still reduce the incidence of IV catheter complications, while resulting in a faster onset and higher quality of analgesia relative to predistension with saline.

There is lack of research examining the potential benefits and risks of initiating labor analgesia with injection of anesthetic medications through the epidural needle. We hypothesized that needle injection of a loading dose of bupivacaine directly into the epidural space would shorten analgesic onset and improve the quality of subsequent labor analgesia compared to catheter injection.

Methods
=======

This study was a prospective, randomized, double-blind trial involving healthy adult parturients in spontaneous labor or induction of labor following an uncomplicated pregnancy. Enrollment for this trial spanned from January 17, 2013 to January 24, 2014 at The Ohio State University Wexner Medical Center. The protocol was approved by the Ohio State University Biomedical Research Institutional Review Board prior to the start of recruitment and is registered on [ClinicalTrials.gov](http://ClinicalTrials.gov) (NCT02883283). The research was conducted using good clinical practices and the highest standards of ethics, as described by the Declaration of Helsinki. Participants were approached and they voluntarily provided written informed consent for this research upon admission to the labor and delivery unit. During the consent process, patients were made aware that they would not know whether the initial epidural medication was being administered through the epidural needle or catheter. Inclusion criteria were uncomplicated obstetric patients aged ≥18 years who were in active labor and requesting epidural analgesia. Exclusion criteria included contraindications to epidural placement, inability to provide informed consent, fetal intrauterine growth restriction, nonreassuring fetal heart tracing, cervical dilation \>7 cm at the time of request for epidural, intrauterine fetal demise, spinal pathology, history of chronic pain, or incarcerated patients. If the practitioners had any suspicion of dural puncture (more than three attempts, or return of clear fluid following loss of resistance), the participant would no longer continue in the study and would receive standard catheter insertion and epidural dosing.

Patients were randomly assigned to either the control group or intervention group by randomly ordering equal numbers of each study group in sequentially numbered opaque envelopes. Upon the participant's request for epidural analgesia, the study group was revealed to an anesthesiologist trained in the research protocol prior to proceeding with epidural placement. A separate investigator blinded to the randomized study group was also present to perform data collection. The blinded investigator was shielded from the anesthesia providers performing the epidural placement and administering medications, so that neither the blinded investigator nor the patient could see if the initial epidural medications were given via the needle or catheter.

Epidural procedures were performed by attending anesthesiologists, obstetric anesthesiology fellows, or anesthesiology residents who had completed at least 50 labor epidural procedures during their training. Patients were placed in the sitting position, the skin over the lumbar area was cleaned with ChloraPrep^®^ (ChloraPrep Skin Prep; CareFusion, El Paso, TX, USA), a sterile drape was applied, and sterile technique was observed throughout the procedure. Skin and subcutaneous tissue were infiltrated with 1% lidocaine 3--5 mL at the intended site of epidural placement. The lumbar epidural space was then located with an 18 gauge Tuohy epidural needle via a loss of resistance technique with 2 mL or less of saline, as it is a standard practice at our institution to perform loss of resistance to saline. BBraun Perifix^®^ONE (B. Braun Medical Inc., Bethlehem, PA, USA) 20 gauge epidural catheters were placed in each patient either before or after administration of epidural medication according to the study group.

The patient's verbal rating scale (VRS) pain score (0--10) during uterine contractions was determined at the time of loss of resistance location of the epidural space and at 5-minute intervals for 20 minutes. In the needle injection group, after successful loss of resistance with saline was obtained, a 10 mL loading dose of 0.125% bupivacaine with fentanyl 2 µg/mL was given in 5 mL increments via the epidural needle spaced 2 minutes apart. Between doses, the patient's blood pressure, heart rate, and symptoms suggestive of IT or IV injection were carefully observed. In order to maintain blinding for the study, anesthesia providers stood behind the patients in the catheter injection group during this time but did not inject any epidural medication. In both study groups, the epidural catheter was then advanced and catheter aspiration performed. If the anesthesia provider was unable to readily advance the catheter in a timely manner or the catheter aspiration was positive for blood or cerebrospinal fluid, then the patient would not continue in the study and their subsequent care would be at the discretion of the anesthesia provider. Five minutes after loss of resistance, the catheter injection group then received the same 10 mL loading dose of 0.125% bupivacaine with fentanyl 2 µg/mL, given in 5 mL increments via the epidural catheter spaced 2 minutes apart. In order to once again maintain patient and investigator blinding, the anesthesia providers stood behind the patients in the needle injection group during this time without giving any epidural medication. It should be noted that the catheter dose was administered 5 minutes after the needle group to ensure that equal timing of VRS pain score and sensory blockade level assessments after medication injection would occur with both study groups, as these parameters were recorded at baseline and thereafter at 5-minute intervals. Three minutes after the last epidural catheter dose was given (or not given for patients in the needle injection group), both study groups received an epidural test dose of 1.5% lidocaine with epinephrine 1:200,000 3 mL to look for signs of IV or IT catheter placement. The epidural catheter test dose is usually administered prior to giving other medications through the epidural catheter, though for the purposes of this investigation, it was determined that the same epidural medications should be administered in the same order to enable more equal comparison of onset of pain relief and sensory blockade measured from the time of injection between study groups. Further, careful patient observation, catheter aspiration, and incremental dosing were determined to be reasonable safeguards against IV or IT administration of medication. All patients then received a standard epidural infusion of 0.0625% bupivacaine with fentanyl 2 µg/mL at 10 mL/h with patient-controlled epidural analgesia (PCEA) 10 mL doses, 20-minute lockout.

Participants were asked to rate the pain of their most recent uterine contraction on a VRS of 0--10 every 5 minutes (0=no pain, 10=worst pain imaginable) for 20 minutes beginning at the time loss of resistance occurred and just prior to the first potential dose of local anesthetic through the epidural needle. The sensory level was determined by loss of sharpness to pinprick with a blunt tip needle recorded every 5 minutes for 20 minutes after loss of resistance location of the epidural space. Primary outcome measures used to compare the epidural needle- and epidural catheter-based loading techniques included rates of analgesic (VRS/minute) and sensory blockade onset (sensory level/minute). Time to VRS ≤3 was also recorded for both groups. Maternal heart rate, fetal heart rate, and maternal blood pressure measurements were used to assess the safety profiles between study groups and were recorded every 2 minutes for 20 minutes after successful location of the epidural space. Occurrence of adverse events, such as accidental IV or IT injection of medications, was recorded. The number of PCEA demand doses and the total volume of anesthetic infused were used as metrics to assess the effectiveness of analgesia throughout the duration of labor, and these parameters were recorded after delivery. Patient satisfaction scores (0--10) were determined during routine follow-up visits 1 day after delivery.

The desired sample size for the study was 50 in total (60 were enrolled to allow for removing patients after enrollment), 25 patients per group to detect a 1.5-fold difference in rate of VRS pain score change with more than 80% and an alpha level of 0.05, assuming a conservative coefficient of variation of 50% for slopes across patients within each group. No pilot data or previously published studies were available to do the sample size calculation, though it was considered that a 1.5-fold difference between the two groups in VRS pain score would be clinically meaningful. Data were analyzed using Statistical Analysis Software, version 9.3, applying linear mixed model regression analyses for fixed and random effects between groups, while a random effect regression analysis was conducted to estimate the slopes of the outcomes over continuous time for both groups. Sandwich estimator was used to control the correlation because of the dependence of the observations among repeated measurements. Student's *t*-test, chi-square test, and Wilcoxon--Mann--Whitney test were used to analyze demographic variables, with alpha=0.05.

Results
=======

Sixty patients were enrolled to participate in this investigation. Protocol deviations occurred in 4 cases, leaving 29 patients in the catheter injection group and 27 patients in the needle injection group to be considered for the analysis. There were no significant differences in demographic or labor characteristics between the study groups ([Table 1](#t1-jpr-10-2789){ref-type="table"}). The rate of pain relief (VRS pain score/minute) from the time of medication injection and the rate of sensory block onset (sensory level/minute) were used as primary metrics to compare the effectiveness between delivering the loading dose via the epidural needle and the epidural catheter. The estimated difference in rate of pain relief (slope) from the time of medication dosing, reported as VRS pain score/minute, between the epidural needle and epidural catheter groups was 0.04 (95% CI: −0.01 to 0.11) and not statistically significant (*p*=0.109; [Figure 1](#f1-jpr-10-2789){ref-type="fig"} and [Table 2](#t2-jpr-10-2789){ref-type="table"}). Notably, 13 of 29 patients who were dosed through the epidural catheter reported uterine contraction pain relief prior to receiving the initial dose of epidural medication. The estimated difference in analgesic spread (spinal level/minute), as defined by loss of sharpness of pinprick, was 0.63 (95% CI: −0.12 to 0.19) and did not significantly differ between groups (*p*=0.166; [Figure 2](#f2-jpr-10-2789){ref-type="fig"} and [Table 2](#t2-jpr-10-2789){ref-type="table"}). The time to VRS ≤3 for the epidural needle and catheter groups were 12.5±5.28 and 12.61±5.38 minutes (*p*=0.942; [Table 2](#t2-jpr-10-2789){ref-type="table"}), respectively.

There was no significant difference observed in the average number of PCEA demand doses, with 5.85 and 4.62 PCEA doses in the needle and catheter injection groups, respectively (*p*=0.384; [Table 2](#t2-jpr-10-2789){ref-type="table"}). The average total volume of anesthetic infused were 116.6 and 113.6 mL for the needle and catheter injection groups, respectively (*p*=0.901; [Table 2](#t2-jpr-10-2789){ref-type="table"}). The mean number of clinician-administered epidural doses for rescue analgesia were 1.17 and 1.67 (*p*=0.209; [Table 2](#t2-jpr-10-2789){ref-type="table"}) in the needle and catheter injection groups, respectively.

No significant difference was observed in the estimated slope differences of maternal mean arterial blood pressure (0.25, *p*=0.188; [Figure 3](#f3-jpr-10-2789){ref-type="fig"}) or maternal heart rate (0.03, *p*=0.807; [Figure 4](#f4-jpr-10-2789){ref-type="fig"}). No occurrence of fetal bradycardia was observed in the first 20 minutes after epidural medication dosing in either study group. No adverse events occurred in either study group. Patients were asked to rate their satisfaction (0--10) during routine follow-up visit 1 day after delivery and no significant differences were observed between study groups (needle injection: 9.2, catheter injection: 8.75, *p*=0.521; [Table 2](#t2-jpr-10-2789){ref-type="table"}).

Discussion
==========

We hypothesized that needle injection of epidural medications would shorten analgesic onset measured from the time of injection and improve the quality of subsequent labor analgesia compared to catheter injection, potentially because we thought faster injection from a more posterior location within the epidural space and improved medication spread may be possible with needle compared to catheter dosing.[@b5-jpr-10-2789],[@b8-jpr-10-2789]--[@b10-jpr-10-2789] However, we observed similar rates of analgesic and sensory blockade onset measured from the time of medication injection. The quality of subsequent labor analgesia was also similar between study groups, as reflected by similar PCEA usage, clinician-administered epidural boluses, and total volume of local anesthetic administered. Instead, it may have been beneficial to measure analgesic onset from the time of epidural space location rather than from the time of injection, as this may have demonstrated a benefit in terms of shortening onset of pain relief after needle injection. Measuring analgesic onset from the time of successful location of the epidural space is also arguably a better reflection of actual clinical practice, as needle injection can be performed prior to catheter insertion, aspiration, test dosing, catheter securing, and eventual catheter dosing. Importantly, the incidence of side effects was also observed to be similar between study groups, as no statistically significant differences in maternal mean arterial blood pressure, heart rate, or incidence of fetal bradycardia were observed. However, adequate statistical power was not achieved to study the safety profile of epidural needle loading compared to catheter loading. Further investigation is warranted to more fully establish the safety of dosing through the epidural needle.

A further limitation of this study was that VRS pain scores were recorded only every 5 minutes for 20 minutes after the initial epidural dose and the rate of pain relief (pain score/minute) was reported as an outcome measure. Gambling et al asked the patient to inform the investigator when she rated contraction pain 0 or 1 (0--10 scale), which may have been a more accurate means of determining onset of analgesia in the present investigation.[@b3-jpr-10-2789] Another recent investigation assessed time from initial epidural dosing to a VRS pain score ≤3, and observed analgesic onset of 9.2 and 16 minutes in the different study groups.[@b13-jpr-10-2789] Patients may often achieve initial satisfactory labor analgesia within 20 minutes of dosing the initial epidural medication, but we acknowledge that some patients may not have effective pain relief in this time frame and a longer period of assessment should have been performed.

The optimal volume, local anesthetic concentration, and dose interval necessary to appreciate a potential benefit of dosing through the epidural needle have not been established. It is possible that administering the anesthetic solution in 5 mL increments separated by 2 minutes may have represented inadequate volume being delivered too slowly to appreciate any potential benefit of dosing through the epidural needle. The effectiveness of administering the initial bolus incrementally via the epidural needle over several minutes time may have provided greater patient safety, but limited the potential benefit in regard to shortening onset of labor analgesia and improving spread of medication. Anecdotally, larger volumes of local anesthetic given over a shorter time interval may achieve greater spread of medication and shorten the onset of analgesia. There have been considerable differences in volume and dosing intervals among studies examining dosing through the epidural needle, particularly amongst studies in obstetric[@b6-jpr-10-2789] and non-obstetric[@b5-jpr-10-2789],[@b7-jpr-10-2789] patients undergoing surgery. Only one of these reports suggested benefit of dosing through the epidural needle and reported superior surgical conditions in non-obstetric patients who received 2% lidocaine 20 mL as a single injection via the epidural needle compared to the catheter.[@b5-jpr-10-2789] We are aware of only one recent study in which laboring patients were given 15 mL of local anesthetic divided into three doses, but this dosing method was compared to CSE labor analgesia in that investigation.[@b3-jpr-10-2789] Given the potential importance of bolus volume administered and dosing interval, further investigation with increased volume and decreased time interval for injection is necessary to better evaluate the utility of epidural needle bolus dosing.

Interestingly, 13 of 29 patients in the epidural catheter group reported pain relief prior to receiving the initial bolus of anesthetic solution, suggesting a placebo effect. The blinded design of the study necessitated that patients not be aware of whether the medication was administered through the epidural needle or catheter, but the catheter medication was administered 5 minutes later. Therefore, patients in the epidural catheter group had a 5-minute time period of perceived pain reduction after loss of resistance was obtained, which may have artificially lowered patient-reported pain scores when compared with the pain scores of patients in the epidural needle group, who received the initial bolus immediately after loss of resistance was obtained. We are not aware of any evidence that saline used for loss of resistance would have an analgesic effect, and the saline volume was limited to 2 mL or less in this study. Previous authors have pointed out that patients can experience pain and anxiety during infiltration with lidocaine or labor epidural placement.[@b14-jpr-10-2789] One previous study observed slightly higher numerical verbal pain scores (0--10) after local anesthetic infiltration compared to just before threading the epidural catheter.[@b15-jpr-10-2789] It is possible that in the present investigation, some of the patient-reported pain was related to the epidural procedure itself, and the lowering of VRS pain scores in the catheter group prior to receiving epidural medication may be a reflection of a longer period of time between the epidural needle placement and medication dosing.

Some providers prefer to perform CSE procedures when shorter onset of pain relief is desired. CSE techniques have been shown to improve the onset[@b3-jpr-10-2789] and reliability[@b3-jpr-10-2789],[@b16-jpr-10-2789]--[@b18-jpr-10-2789] of labor analgesia relative to epidural techniques, but it is not always possible to administer a spinal dose despite successful loss of resistance.[@b19-jpr-10-2789] CSEs also have several potential drawbacks, including greater incidence of nonreassuring fetal heart tones (FHT), uterine hyperactivity, maternal pruritis, and neurologic sequelae compared to epidural analgesia.[@b20-jpr-10-2789]--[@b23-jpr-10-2789] Furthermore, it has been reported that CSE labor analgesia is more likely to result in prolonged FHT decelerations if there are FHT abnormalities prior to the neuraxial procedure.[@b24-jpr-10-2789] It is our opinion that initiation of labor analgesia via the epidural needle could be advantageous in situations where slightly faster onset of analgesia is desired and CSE may not be possible or is considered a less favorable technique.

There is some concern that dosing prior to catheter placement, such as with a CSE or through the epidural needle, may impair the ability to detect an ineffective catheter in a timely manner and it may not be reliable if a surgical intervention is necessary. There were no epidural catheter replacements in either group during this investigation, but our study was not adequately powered to detect potential delayed recognition of a failed catheter. It should be noted that recent investigations have observed that performing a CSE did not delay the time to recognition of a failed epidural catheter,[@b17-jpr-10-2789],[@b18-jpr-10-2789] though we are not aware of any studies specifically examining potential delayed recognition of a failed catheter after dosing through the epidural needle. The safety of administering a bolus dose through the epidural needle may also be questioned, though no severe complications such as inadvertent IV or IT injection were observed in our investigation or in previous reports.[@b3-jpr-10-2789],[@b5-jpr-10-2789]--[@b7-jpr-10-2789] It has been demonstrated that careful aspiration and observation by an experienced anesthesia provider along with incremental medication injection without test dosing may effectively safeguard against IV or IT catheter placement.[@b25-jpr-10-2789] In our experience, incremental dosing through the epidural needle with close patient observation is a safe means of initiating labor analgesia in a timely manner, though it should be recognized that the present investigation was not sufficiently powered to study safety outcomes.

Conclusion
==========

Our comparison of initiating labor analgesia with injection of epidural medication through the needle versus the catheter did not find any significant differences in onset of analgesia from the time of injection, quality of analgesia, or level of sensory blockade. We did not, however, find an increased incidence of side effects or complications when dosing through the epidural needle. Previous reports have also failed to demonstrate complications with this technique.[@b3-jpr-10-2789],[@b5-jpr-10-2789]--[@b7-jpr-10-2789] Given the safety and the theoretical benefit, future investigations where analgesic onset is measured from the time of epidural space location rather than from the time of epidural medication injection, or where larger volumes of epidural medication are administered may be worthwhile.
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![VRS pain score (0--10) as a function of time (minutes) for 20 minutes after the initial epidural dose was administered.\
**Notes:** Data are mean±SD. Time=0, time of the initial bolus dose.\
**Abbreviation:** VRS, verbal rating scale.](jpr-10-2789Fig1){#f1-jpr-10-2789}

![Thoracic sensory level as a function of time (minutes) for 20 minutes after the initial epidural dose was administered.\
**Notes:** Data are mean±SD. Time=0, time of the initial bolus dose.](jpr-10-2789Fig2){#f2-jpr-10-2789}

![Maternal mean arterial pressure (mmHg) as a function of time (minutes) for 20 minutes after the initial epidural dose was administered.\
**Notes:** Data are mean±SD. Time=0, time of the initial bolus dose.](jpr-10-2789Fig3){#f3-jpr-10-2789}

![Maternal heart rate (beats per minute) as a function of time (minutes) for 20 minutes after the initial epidural dose was administered.\
**Notes:** Data are mean±SD. Time=0, time of the initial bolus dose.](jpr-10-2789Fig4){#f4-jpr-10-2789}

###### 

Participant characteristic averages per randomization group

  Participant characteristics   Catheter     Tuohy needle   *p*-value
  ----------------------------- ------------ -------------- -----------
  Age (years)                   27.6±0.97    27.0±1.01      0.660
  Height (in.)                  65.1±0.52    64.7±0.52      0.637
  Weight (pounds)               184.3±9.5    204.4±9.82     0.148
  Dilation (cm)                 3.4±0.24     3.3±0.28       0.683
  Gravidity                     2.3±0.27     2.1±0.27       0.59
  Station (cm)                  −2(−3, −1)   −2(−2, −1)     0.353

**Notes:** Statistical differences calculated between participants in each randomized group. Data are mean ± SD.

###### 

Outcomes for pain relief, sensory blockade, quality of labor analgesia, side effects, adverse events, and patient satisfaction

  ------------------------------------------------------------------------------------------------------------------------------
  Outcome                                                                        Catheter dosing\   Needle dosing\   *p*-value
                                                                                 (n=29)             (n=27)           
  ------------------------------------------------------------------------------ ------------------ ---------------- -----------
  Rate of pain relief (VRS pain score/minute)                                    4.81±0.36          4.85±0.35        0.109

  Rate of sensory blockade (spinal level/minute)                                 13.26±0.56         13.89±0.59       0.166

  VRS pain score prior to epidural dosing (0--10 scale)                          7.60±1.70          8.04±1.53        0.323

  Time to VRS pain score ≤3 (minutes)                                            12.61±5.38         12.5±5.28        0.942

  Sensory level 20 minutes after dosing (mean)                                   T9.46              T8.87            NA

  Clinician-administered rescue doses during labor (n)                           1.67±0.81          1.17±0.40        0.209

  Number of PCEA demand doses during labor (n)                                   4.62±3.57          5.85±3.50        0.384

  Volume of anesthetic infused during labor (mL)                                 113.6±77.05        116.6±2.79       0.901

  Epidural catheter replacement (n)                                              0                  0                NA

  Hypotension requiring treatment with vasopressor (n)                           0                  1                NA

  Fetal bradycardia in the first 20 minutes after dosing (n)                     0                  0                NA

  Adverse events (e.g., accidental intravascular or intrathecal injection) (n)   0                  0                NA

  Patient satisfaction score (0--10)                                             8.75±1.77          9.2±1.61         0.521
  ------------------------------------------------------------------------------------------------------------------------------

**Note:** Data are mean ± SD.

**Abbreviations:** NA, not applicable; PCEA, patient-controlled epidural analgesia; VRS, verbal rating scale.
